Heineman Thomas Charles bought ONCY
February 12, 2026 · Form 4 insider transaction
Heineman Thomas Charles bought 12,132 shares of Oncolytics Biotech Inc. at $0.83 per share, a transaction worth $10.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,132
Price
$0.83
Total value
$10.0K
InsiderHeineman Thomas Charles
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateFebruary 12, 2026
Filing dateFebruary 13, 2026
Shares owned after282,818
OwnershipDirect
10b5-1 planNo
AmendedNo